BDX - Becton, Dickinson and Company
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $2.25
|
Rev Est: $4.8B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$193.80
DETAILS
HIGH:
$215.00
LOW:
$170.00
MEDIAN:
$202.00
CONSENSUS:
$193.80
UPSIDE:
6.20%
Market Cap:
66.12B
Volume:
2,895,401
Avg Volume:
2,671,481
52 Week Range:
127.58648-187.35
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.28
Last Dividend:
$3.28
Exchange:
NYSE
Country:
US
Employees:
70,000
IPO Date:
1973-02-21
EPS (TTM):
5.84
P/E Ratio:
19.76
Revenue (TTM):
21.84B
Total Assets:
55.33B
Total Debt:
19.18B
Cash & Equiv:
851.00M
Rev Growth (5Y):
6.3%
EPS Growth (5Y):
16.3%
FCF Growth (5Y):
-0.4%
ROCE:
5.3%
Debt/Equity:
0.76
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-09 | $2.91 | $2.21 | +31.7% | $5.3B | $5.1B | +2.0% |
| 2025-11-06 | $3.96 | $3.92 | +1.0% | $5.9B | $5.9B | -0.3% |
| 2025-08-07 | $3.68 | $3.40 | +8.2% | $5.5B | $5.5B | +0.4% |
| 2025-05-01 | $3.35 | $3.28 | +2.1% | $5.3B | $5.4B | -1.5% |
| 2025-02-05 | $3.43 | $3.00 | +14.3% | $5.2B | $5.1B | +1.3% |
| 2024-11-07 | $3.81 | $3.77 | +1.1% | $5.4B | $5.4B | +1.1% |
| 2024-08-01 | $3.50 | $3.31 | +5.7% | $5.0B | $5.1B | -1.7% |
| 2024-05-02 | $3.17 | $2.97 | +6.7% | $5.0B | $5.0B | +0.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21.84B | 20.18B | 19.37B | 18.87B | 19.13B | 16.07B | 17.29B | 15.98B | 12.09B | 12.48B | 10.28B | 8.45B |
| Net Income | 1.68B | 1.71B | 1.48B | 1.78B | 2.09B | 874.00M | 1.23B | 311.00M | 1.10B | 976.00M | 695.00M | 1.19B |
| EPS | 5.84 | 5.88 | 4.97 | 5.93 | 6.92 | 2.75 | 3.96 | 0.62 | 4.70 | 4.59 | 3.43 | 6.13 |
| Total Assets | 55.33B | 57.29B | 52.78B | 52.93B | 53.88B | 54.01B | 51.84B | 53.90B | 37.73B | 25.59B | 26.82B | 12.45B |
| Total Debt | 19.18B | 20.11B | 15.88B | 16.07B | 17.61B | 17.93B | 19.39B | 21.50B | 18.87B | 11.55B | 12.82B | 3.97B |
| Cash & Equivalents | 851.00M | 1.72B | 1.42B | 1.01B | 2.28B | 2.83B | 536.00M | 1.14B | 14.18B | 1.54B | 1.42B | 1.86B |
| Operating Cash Flow | 3.43B | 3.80B | 2.99B | 2.63B | 4.65B | 3.54B | 3.33B | 2.87B | 2.55B | 2.56B | 1.73B | 1.74B |
| Free Cash Flow | 2.67B | 3.07B | 2.12B | 1.66B | 3.42B | 2.73B | 2.37B | 1.97B | 1.82B | 1.84B | 1.10B | 1.09B |
| FCF per Share | 9.32 | 10.60 | 7.39 | 5.82 | 11.81 | 9.78 | 8.79 | 7.63 | 8.33 | 8.66 | 5.41 | 5.64 |
| Book Value | 25.39B | 25.89B | 25.80B | 25.28B | 23.68B | 23.77B | 21.08B | 20.99B | 12.95B | 7.63B | 7.17B | 5.05B |
| Cash & ST Investments | 859.00M | 2.16B | 1.42B | 1.01B | 2.29B | 2.85B | 566.00M | 1.16B | 14.22B | 1.91B | 1.52B | 2.75B |
| ROC Equity | 0.07 | 0.07 | 0.06 | 0.07 | 0.09 | 0.04 | 0.06 | 0.01 | 0.08 | 0.13 | 0.10 | 0.23 |